habener glp-1 TIME100 Health: Joel Habener, Dan Drucker, Svetlana Mojsov and Jens Juul Holst Life in the Balance: 2025

We go above and beyond what is required by the FDA for supplement companies

There is no clinical evidence suggesting that oral supplements interfere with injectable GLP-1 medications, so timing relative to injection day is not a significant concern

(PubMed) Haskell CF, Scholey AB, Jackson PA, et al

Our findings show that DET1 serves as a structural scaffold, connecting COP1 to DDD and Ube2e2 enzymes, while DDB1 recruits the CULLIN4-RBX1 complex

520 Imvax is conducting a randomized, multicenter, double-blind, placebo-controlled Phase IIb study (NCT04485949) to evaluate IGV-001 in patients with newly diagnosed GBM

And research like this brings us one step closer to that vision